HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis
Clinical trial NCT05648487 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05648487
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-03-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.